BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16598333)

  • 21. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.
    Aziz HA; Boutrid H; Murray TG; Berrocal A; Wolfe SQ; Pina Y; Dorfman M; Moftakhar R; Fernandes CE; Reichbach J; Aziz-Sultan MA
    Retina; 2010 Apr; 30(4 Suppl):S63-5. PubMed ID: 20224464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group.
    Chantada GL; Doz F; Orjuela M; Qaddoumi I; Sitorus RS; Kepak T; Furmanchuk A; Castellanos M; Sharma T; Chevez-Barrios P; Rodriguez-Galindo C;
    Pediatr Blood Cancer; 2008 Mar; 50(3):692-4. PubMed ID: 18059037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
    Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
    Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An unusual variant of diffuse retinoblastoma in an adult.
    Khanfir K; Chompret A; Frau E; Bloch-Michel E; Tursz T; Le Cesne A
    Acta Oncol; 2008; 47(5):973-4. PubMed ID: 17943473
    [No Abstract]   [Full Text] [Related]  

  • 26. Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma.
    Kawamura J; Sakurai M; Tsukamoto K; Tochigi H
    Urol Int; 1993; 51(1):49-53. PubMed ID: 8333092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cyclophosphamide-induced bladder cancer: three case reports].
    Kijima T; Masuda H; Suzuki M; Okada Y; Yano M; Hyochi N; Fujii Y; Kawakami S; Hayashi T; Kobayashi T; Kihara K
    Hinyokika Kiyo; 2003 Aug; 49(8):483-6. PubMed ID: 14518387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW
    Int Ophthalmol Clin; 2015; 55(1):77-96. PubMed ID: 25436495
    [No Abstract]   [Full Text] [Related]  

  • 30. Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report.
    Nakamoto T; Kasaoka Y; Ikegami Y; Usui T
    Hiroshima J Med Sci; 2000 Jun; 49(2):121-3. PubMed ID: 10920579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of cyclooxygenase 2 in retinoblastoma: primary enucleated eyes and enucleation after conservative treatment.
    Souza Filho JP; Martins MC; Correa ZM; Odashiro AN; Antecka E; Coutinho AB; Macedo CR; Vianna RN; Burnier MN
    Am J Ophthalmol; 2006 Oct; 142(4):625-31. PubMed ID: 17011855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transglabellar/subcranial approach for surgical excision of periocular second tumors in retinoblastoma.
    Demirci H; Marentette LJ; Nelson CC
    Orbit; 2008; 27(4):285-91. PubMed ID: 18716966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical manifestations and treatment of retinoblastoma in Korea.
    Chung SE; Sa HS; Koo HH; Yoo KH; Sung KW; Ham DI
    Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder leiomyosarcoma and pelvic fibroblastic tumor following cyclophosphamide therapy.
    Rowland RG; Eble JN
    J Urol; 1983 Aug; 130(2):344-6. PubMed ID: 6876288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Strategies in the Treatment of Unilateral Sporadic Retinoblastoma.
    Shields CL; Shields JA
    J Pediatr Ophthalmol Strabismus; 2015; 52(3):134-7. PubMed ID: 26053204
    [No Abstract]   [Full Text] [Related]  

  • 36. A perspective on chemoreduction and focal therapy for retinoblastoma.
    Balasubramanya R; Pushker N; Bajaj MS; Ghose S; Rani A
    Am J Ophthalmol; 2002 Oct; 134(4):633; author reply 633-4. PubMed ID: 12383837
    [No Abstract]   [Full Text] [Related]  

  • 37. Leiomyosarcoma of the distal femur in a patient with a history of bilateral retinoblastoma: a case report and review of the literature.
    Ryan RS; Gee R; O'Connell JX; Harris AC; Munk PL
    Skeletal Radiol; 2003 Aug; 32(8):476-80. PubMed ID: 12759785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis.
    Thrasher JB; Miller GJ; Wettlaufer JN
    J Urol; 1990 Jan; 143(1):119-21. PubMed ID: 2294239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis.
    Armenian SH; Panigrahy A; Murphree AL; Jubran RF
    Pediatr Blood Cancer; 2008 Oct; 51(4):479-84. PubMed ID: 18478574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
    Wilson MW; Haik BG; Billups CA; Rodriguez-Galindo C
    Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.